“…When platelets become activated, there is a conformational change in GPIIb/IIIa (CD41/ CD61), enabling binding of fibrinogen and vWF, a key mechanism in promoting platelet-platelet aggregation. Most studies have shown that expression of GPIIb/IIIa does not alter throughout storage of PCs to days 7-9 (Sarraj-Reguieg et al, 1993;Metcalfe et al, 1997;Ferrer et al, 2000a,b), is similar in PRP, BC or apheresis PC (Metcalfe et al, 1997) and is not influenced by leucodepletion (Boomgaard et al, 1994c(Boomgaard et al, , 1995. However, this provides little information on whether there are any changes in the function of this receptor, i.e.…”